UMIN ID: UMIN000054278
Registered date:29/04/2024
Reduction in nocturnal urinary frequency and improvement of fatty liver in SGLT-2 inhibitors.
Basic Information
Recruitment status | Recruiting |
---|---|
Health condition(s) or Problem(s) studied | type 2 diabetes |
Date of first enrollment | 2024/04/28 |
Target sample size | 135 |
Countries of recruitment | Japan |
Study type | Interventional |
Intervention(s) | Prescription of 20 mg of tofogliflozin in men and women with type 2 diabetes Prescription of 5 mg of dapagliflozin in men and women with type 2 diabetes Prescription of 10 mg of empagliflozin in men and women with type 2 diabetes |
Outcome(s)
Primary Outcome | Change in the frequency of nocturnal urine (23:00-6:00) |
---|---|
Secondary Outcome | Improvement of fatty liver |
Key inclusion & exclusion criteria
Age minimum | 30years-old |
---|---|
Age maximum | 100years-old |
Gender | Male and Female |
Include criteria | |
Exclude criteria | Insulin users Type 1 diabetes Mental illness Liver cirrhosis Renal failure |
Related Information
Primary Sponsor | University of Occupational and Environmental Health |
---|---|
Secondary Sponsor | |
Source(s) of Monetary Support | none |
Secondary ID(s) |
Contact
public contact | |
Name | Tetsuya Kawahara |
Address | 2-5 Dairishinmachi, Moji, Kitakyushu Japan 800-0057 |
Telephone | 0933911001 |
k-tetsuy@med.uoeh-u.ac.jp | |
Affiliation | Shin Komonji Hospital Endocrinology and Diabetes |
scientific contact | |
Name | Tetsuya Kawahara |
Address | 2-5 Dairishinmachi, Moji, Kitakyushu |
Telephone | +81-93-391-1001 |
k-tetsuy@med.uoeh-u.ac.jp | |
Affiliation | Shin Komonji Hospital Endocrinology and Diabetes |